Does TREPROSTINIL Cause Secretion discharge? 297 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 297 reports of Secretion discharge have been filed in association with TREPROSTINIL (TYVASO). This represents 0.3% of all adverse event reports for TREPROSTINIL.
297
Reports of Secretion discharge with TREPROSTINIL
0.3%
of all TREPROSTINIL reports
16
Deaths
91
Hospitalizations
How Dangerous Is Secretion discharge From TREPROSTINIL?
Of the 297 reports, 16 (5.4%) resulted in death, 91 (30.6%) required hospitalization, and 4 (1.3%) were considered life-threatening.
Is Secretion discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 297 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Secretion discharge?
ADALIMUMAB (685)
DUPILUMAB (626)
ALBUTEROL (520)
OMALIZUMAB (514)
ETANERCEPT (487)
METHOTREXATE (387)
MEPOLIZUMAB (359)
BUDESONIDE\FORMOTEROL (339)
PREDNISONE (316)
SECUKINUMAB (307)
Which TREPROSTINIL Alternatives Have Lower Secretion discharge Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE